» Articles » PMID: 24370119

The Role of IFITM3 in the Growth and Migration of Human Glioma Cells

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2013 Dec 28
PMID 24370119
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Interferon induced transmembrane protein 3 (IFITM3) is transcribed in most tissues and highly interferon-inducible. However, the role of IFITM3 in cancer is still poorly understood.

Methods: Expression levels of IFITM3 were analyzed in 60 glioma patients by immunohistochemistry (IHC). Following closely, we investigated the phenotype of IFITM3 knockdown on glioma cell growth and tumorigenesis in vitro using lentivirus-mediated loss-of-function strategy.

Results: Depletion of IFITM3in U251 cells dramatically inhibited cell proliferation and colony formation, which demonstrated that reduced IFITM3 protein levels could cause inhibition of tumorigenesis. Knockdown of IFITM3 also induced cell cycle arrest in G0/G1 phase, especially in the sub-G1 phase representing apoptotic cells. In addition, the migration of U251 cells was visibly weakened after IFITM3 knockdown, as determined by Transwell assay.

Conclusions: Our findings provide new evidence that IFITM3 plays an important role in glioma cell growth and migration, suggesting that silencing of IFITM3 by RNA interference (RNAi) may be a potential approach to suppress glioma growth.

Citing Articles

Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer.

Wang P, Pan Y, Zhang Y, Chen C, Hu J, Wang X Med Oncol. 2024; 41(4):85.

PMID: 38472606 DOI: 10.1007/s12032-024-02308-6.


Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis.

Zhang J, Shi L, Duan J, Li M, Li C PeerJ. 2024; 12:e16784.

PMID: 38239300 PMC: 10795527. DOI: 10.7717/peerj.16784.


Interferon-induced transmembrane protein 3 in the hippocampus: a potential novel target for the therapeutic effects of recombinant human brain natriuretic peptide on sepsis-associated encephalopathy.

Li N, Ma R, Zhang E, Ge F, Fang D, Zhang J Front Mol Neurosci. 2023; 16:1182005.

PMID: 37602193 PMC: 10436203. DOI: 10.3389/fnmol.2023.1182005.


Peptidomic changes in human serous colorectal cancer patients.

Xu J, Li X, Chen W, Cheng S, Cheng J, Chen C J Gastrointest Oncol. 2023; 14(2):705-718.

PMID: 37201060 PMC: 10186523. DOI: 10.21037/jgo-23-188.


Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer.

Mazumder S, Mitra Ghosh T, Mukherjee U, Chakravarti S, Amiri F, Waliagha R Cancers (Basel). 2022; 14(23).

PMID: 36497496 PMC: 9738762. DOI: 10.3390/cancers14236009.


References
1.
El-Tanani M, Jin D, Campbell F, Johnston P . Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression. Oncogene. 2009; 29(5):752-62. DOI: 10.1038/onc.2009.379. View

2.
Pollo B . Neuropathological diagnosis of brain tumours. Neurol Sci. 2011; 32 Suppl 2:S209-11. DOI: 10.1007/s10072-011-0802-2. View

3.
Yu F, Ng S, Chow B, Sze J, Lu G, Poon W . Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells. J Neurooncol. 2010; 103(2):187-95. PMC: 3097340. DOI: 10.1007/s11060-010-0377-4. View

4.
Liu B, Cheng J, Zhang X, Zhang W . Controversies concerning the application of brachytherapy in central nervous system tumors. J Cancer Res Clin Oncol. 2009; 136(2):173-85. DOI: 10.1007/s00432-009-0741-y. View

5.
Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001; 411(6836):494-8. DOI: 10.1038/35078107. View